Safety and Antiviral Activity of Assembly Biosciences’ First and Second Generation Core Inhibitor Candidates In the Treatment of Chronic Hepatitis B to be Featured in a Late Breaking Session at AASLDGlobeNewsWire • 10/16/19
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/09/19